Down-regulated expression of apoptosis-associated genes APIP and UACA in non-small cell lung carcinoma

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 2111-2121

  Moravcikova, Erika ^a,b   Krepela, Evzen ^a,b   Prochazka, Jan ^a   Rousalova, Ilona ^a   Cermak, Jan ^a   Benkova, Kamila ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apaf 1; APIP; Apoptosis; Expression; Non small cell lung carcinoma; Nuclear factor B; UACA

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; APOPTOSOME; APOPTOTIC PROTEASE ACTIVATION FACTOR 1 INTERACTING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; UVEAL AUTOANTIGEN WITH COILED COIL DOMAINS AND ANKYRIN REPEATS;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; DNA DAMAGE CHECKPOINT; DNA METHYLATION; FEMALE; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RNA ISOLATION; SARCOMATOID CARCINOMA; SMOKING; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOANTIGENS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC; TRANSCRIPTION, GENETIC;

EID: 84861788461     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1397     Document Type: Article

References (48)

1. Jiang X and Wang X: Cytochrome C-mediated apoptosis. Annu Rev Biochem 73: 87-106, 2004. (Pubitemid 39050364)
2. Malladi S, Challa-Malladi M, Fearnhead HO and Bratton SB: The Apaf-1•procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EMBO J 28: 1916-1925, 2009.
3. Yuan S, Yu X, Asara JM, Heuser JE, Ludtke SJ and Akey CW: The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 19: 1084-1096, 2011.
4. Moroni MC, Hickman ES, Denchi EL, et al: Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3: 552-558, 2001. (Pubitemid 32536851)
5. Nahle Z, Polakoff J, Davuluri RV, et al: Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4: 859-864, 2002. (Pubitemid 35331360)
6. De Zio D, Bordi M, Tino E, et al: The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage. Cell Death Differ 18: 516-527, 2011.
7. Gomyo Y, Sasaki J, Branch C, Roth JA and Mukhopadhyay T: 5-Aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells. Oncogene 23: 6779-6787, 2004. (Pubitemid 39280009)
8. Christoph F, Hinz S, Weikert S, Kempkensteffen C, Schostak M, Miller K and Schrader M: Comparative promoter methylation analysis of p53 target genes in urogenital cancers. Urol Int 80: 398-404, 2008. (Pubitemid 351915027)
9. Schafer ZT and Kornbluth S: The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10: 549-561, 2006.
10. Bratton SB and Salvesen GS: Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 123: 3209-3214, 2010.
11. Johnson CE, Huang YY, Parrish AB, et al: Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci USA 104: 20820-20825, 2007.
12. Schafer ZT, Parrish AB, Wright KM, Margolis SS, Marks JR, Deshmukh M and Kornbluth S: Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res 66: 2210-2218, 2006.
13. Niedojadlo K, Labedzka K, Lada E, Milewska A and Chwirot BW: Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. Pigment Cell Res 19: 43-50, 2006.
14. Leo C, Horn LC, Rauscher C, et al: Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer. Clin Cancer Res 13: 1149-1153, 2007. (Pubitemid 46424054)
15. Zlobec I, Minoo P, Baker K, et al: Loss of Apaf-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer. Eur J Cancer 43: 1101-1107, 2007. (Pubitemid 46486708)
16. Wolf BB, Schuler M, Li W, et al: Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 276: 34244-34251, 2001.
17. Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H and Nunez G: Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 62: 924-931, 2002. (Pubitemid 34126974)
18. Tan L, Kwok RP, Shukla A, Kshirsagar M, Zhao L, Opipari AW Jr and Liu JR: Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. Cancer 117: 784-794, 2011.
19. Shinoura N, Sakurai S, Asai A, Kirino T and Hamada H: Over-expression of Apaf-1 and caspase-9 augments radiation-induced apoptosis in U-373MG glioma cells. Int J Cancer 93: 252-261, 2001. (Pubitemid 32574282)
20. Corvaro M, Fuoco C, Wagner M and Cecconi F: Analysis of apoptosome dysregulation in pancreatic cancer and of its role in chemoresistance. Cancer Biol Ther 6: 209-217, 2007. (Pubitemid 46641625)
21. Krepela E, Prochazka J, Liu X, Fiala P and Kinkor Z: Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma. Biol Chem 385: 153-168, 2004. (Pubitemid 38461336)
22. Hoffarth S, Zitzer A, Wiewrodt R, et al: pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ 15: 161-170, 2008. (Pubitemid 350286184)
23. Checinska A, Giaccone G, Hoogeland BS, Ferreira CG, Rodriguez JA and Kruyt FA: TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells. BMC Cancer 6: 166, 2006.
24. Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G and Kruyt FA: Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Exp Cell Res 313: 1215-1224, 2007. (Pubitemid 46427812)
25. Cho DH, Hong YM, Lee HJ, Woo HN, Pyo JO, Mak TW and Jung YK: Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting protein. J Biol Chem 279: 39942-39950, 2004. (Pubitemid 39258267)
26. Cao G, Xiao M, Sun F, et al: Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. J Neurosci 24: 6189-6201, 2004. (Pubitemid 38891110)
27. Cho DH, Lee HJ, Kim HJ, Hong SH, Pyo JO, Cho C and Jung YK: Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2. Oncogene 26: 2809-2814, 2007. (Pubitemid 46663835)
28. Yamada K, Senju S, Nakatsura T, et al: Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 280: 1169-1176, 2001. (Pubitemid 32924463)
29. Sakai T, Liu L, Shishido Y and Fukui K: Identification of a novel, embryonal carcinoma cell-associated molecule, nucling, that is up-regulated during cardiac muscle differentiation. J Biochem 133: 429-436, 2003. (Pubitemid 36604687)
30. Ohkura T, Taniguchi S, Yamada K, et al: Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease. Biochem Biophys Res Commun 321: 432-440, 2004. (Pubitemid 39055764)
31. Sakai T, Liu L, Teng X, et al: Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J Biol Chem 279: 41131-41140, 2004. (Pubitemid 39287715)
32. Liu L, Sakai T, Tran NH, Mukai-Sakai R, Kaji R and Fukui K: Nucling interacts with nuclear factor-kappaB, regulating its cellular distribution. FEBS J 276: 1459-1470, 2009.
33. Travis WD, Brambilla E, Müller-Hermelink HK and Harris CC (eds): Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004.
34. Detterbeck FC, Boffa DJ and Tanoue LT: The new lung cancer staging system. Chest 136: 260-271, 2009.
35. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
36. Smith PK, Krohn RI, Hermanson GT, et al: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985. (Pubitemid 16258399)
37. Schägger H and von Jagow G: Tricine-sodium dodecylsulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368-379, 1987. (Pubitemid 18004907)
38. Shames DS, Girard L, Gao B, et al: A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 3: e486, 2006.
39. Chen Y, Cui T, Knosel T, Yang L, Zoller K and Petersen I: IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Lung Cancer 73: 38-44, 2011.
40. Fujikane T, Nishikawa N, Toyota M, et al: Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat 122: 699-710, 2010.
41. Teng X, Sakai T, Liu L, Sakai R, Kaji R and Fukui K: Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in nucling-deficient mice via suppression of the apoptosome pathway. J Neurochem 97: 1126-1135, 2006.
42. Sakai T, Liu L, Teng X, et al: Inflammatory disease and cancer with a decrease in Kupffer cell numbers in nucling-knockout mice. Int J Cancer 126: 1079-1094, 2010.
43. Graves EE, Maity A and Le QT: The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol 20: 156-163, 2010.
44. Järvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, Grenman R, Makitie AA and Monni O: High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 47: 500-509, 2008. (Pubitemid 351657185)
45. Besse B, Cande C, Spano JP, et al: Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer. Clin Cancer Res 10: 5665-5669, 2004. (Pubitemid 39180940)
46. Zermati Y, Mouhamad S, Stergiou L, et al: Non-apoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell 28: 624-637, 2007. (Pubitemid 350137804)
47. Chaturvedi MM, Sung B, Yadav VR, Kannappan R and Aggarwal BB: NF-kappaB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30: 1615-1630, 2011.
48. Chen W, Li Z, Bai L and Lin Y: NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci 16: 1172-1185, 2011.